1. At a Glance
₹1,913 Cr market cap, ₹902 stock price, and a P/E of 52 — Sika Interplant is priced like a defence startup that already thinks it’s HAL’s younger cousin. Quarterly sales at ₹50.3 Cr and PAT at ₹9.49 Cr show ~32% growth, which sounds impressive… until you realize the absolute size is still chai money for big defence players. ROCE at 29% and almost zero debt? Nice. But trading at 13x book value? That’s premium territory where expectations are higher than IPL ticket prices.
So the real question:
Is this a future aerospace powerhouse… or just a small-cap with big dreams and bigger valuation?
2. Introduction
Imagine a company working on fighter aircraft parts, rescue systems, and defence electronics… but still doing ₹50 Cr quarterly revenue.
Welcome to Sika Interplant — the kind of company that sounds like it should be ₹50,000 Cr but is still figuring out how to scale.
It operates in Aerospace, Defence, Space, and Automotive — basically all the “cool” sectors investors love. Add HAL MoUs, Collins Aerospace partnerships, and MRO licenses… and suddenly this feels like a LinkedIn profile that screams “global ambition”.
But markets don’t reward ambition. They reward execution.
And right now, Sika is somewhere between:
- “Promising niche defence player”
- and “Overvalued smallcap waiting to grow into its valuation”
Let’s break it down properly.
3. Business Model – WTF Do They Even Do?
Sika Interplant is basically an engineering + defence outsourcing specialist.
They operate across 4 main buckets:
1. Engineering Products (61%)
They
